Last reviewed · How we verify
Furazolidone Tablets
Furazolidone Tablets is a Small molecule drug developed by The Third Xiangya Hospital of Central South University. It is currently FDA-approved.
At a glance
| Generic name | Furazolidone Tablets |
|---|---|
| Sponsor | The Third Xiangya Hospital of Central South University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment (PHASE4)
- Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy (PHASE4)
- The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication (EARLY_PHASE1)
- Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment (PHASE3)
- Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy (PHASE4)
- Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine (PHASE1)
- The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers (PHASE4)
- Effect of Probiotics on Helicobacter Pylori Eradication (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Furazolidone Tablets CI brief — competitive landscape report
- Furazolidone Tablets updates RSS · CI watch RSS
- The Third Xiangya Hospital of Central South University portfolio CI
Frequently asked questions about Furazolidone Tablets
What is Furazolidone Tablets?
Furazolidone Tablets is a Small molecule drug developed by The Third Xiangya Hospital of Central South University.
Who makes Furazolidone Tablets?
Furazolidone Tablets is developed and marketed by The Third Xiangya Hospital of Central South University (see full The Third Xiangya Hospital of Central South University pipeline at /company/the-third-xiangya-hospital-of-central-south-university).
What development phase is Furazolidone Tablets in?
Furazolidone Tablets is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing